Reported 9 months ago
UnitedHealth Group's subsidiary, OptumRx Inc., has agreed to a $20 million settlement with the US government for improperly filling certain opioid prescriptions. This settlement has led to a positive movement in UnitedHealth Group's shares, initially up more than 4% but stabilizing around 2.5%. The settlement brings clarity and removes uncertainty surrounding the stock, providing insights into its future prospects.
Source: YAHOO